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With the increase of infections due to multidrug resistant bacterial pathogens and the
shortage of antimicrobial molecules with novel targets, interest in bacteriophages as
a therapeutic option has regained much attraction. Before the launch of future clinical
trials, in vitro studies are required to better evaluate the efficacies and potential pitfalls
of such therapies. Here we studied in an ex vivo human airway epithelial cell line model
the efficacy of phage and ciprofloxacin alone and in combination to treat infection by
Pseudomonas aeruginosa. The Calu-3 cell line and the isogenic CFTR knock down
cell line (cftr-) infected apically with P. aeruginosa strain PAO1 showed a progressive
reduction in transepithelial resistance during 24 h. Administration at 6 h p.i. of single
phage, phage cocktails or ciprofloxacin alone prevented epithelial layer destruction
at 24 h p.i. Bacterial regrowth, due to phage resistant mutants harboring mutations
in LPS synthesis genes, occurred thereafter both in vitro and ex vivo. However, co-
administration of two phages combined with ciprofloxacin efficiently prevented PAO1
regrowth and maintained epithelial cell integrity at 72 p.i. The phage/ciprofloxacin
treatment did not induce an inflammatory response in the tested cell lines as determined
by nanoString R© gene expression analysis. We conclude that combination of phage
and ciprofloxacin efficiently protects wild type and cftr- epithelial cells from infection
by P. aeruginosa and emergence of phage resistant mutants without inducing an
inflammatory response. Hence, phage-antibiotic combination should be a safe and
promising anti-Pseudomonas therapy for future clinical trials potentially including cystic
fibrosis patients.
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INTRODUCTION
Pseudomonas aeruginosa is an opportunistic pathogen, able
to cause acute infections as well as chronic infections in
cystic fibrosis and immuno-compromised patients (Cohen
and Prince, 2012). Designing optimal treatment regimens
against this organism remains a challenge, due to its intrinsic
antibiotic resistance and its ability to develop and acquire
additional antibiotic resistance determinants (Li et al., 2015;
Botelho et al., 2019). Due to the lack of novel antibiotics,
alternative treatment strategies are urgently needed. One
option is bacteriophages (Twort, 1915; d’Hérelle, 1917), which
are natural predators of bacteria. Their use as antimicrobials
predates the antibiotic era. Among them, lytic phages have
been used for many years in the Eastern European countries,
mainly as a topical treatment against bacterial infections
(Kutateladze and Adamia, 2010; Myelnikov, 2018). The
possibility to treat efficiently multidrug resistant (MDR)
bacteria with phages has recently spurred renewed interest
in this field (Gordillo Altamirano and Barr, 2019). Phages
present several advantages over conventional antibiotics, the
major one being their specificity, since they usually target
a single bacterial species, while leaving the host microbiota
unaffected. Secondly, phage replication is dependent on
the presence of the host-bacterium and is therefore self-
limiting. The main concerns for therapeutic use of phages are
the possibility to transfer virulence or antibiotic resistance
genes, requiring in depth analysis of the phages’ genomes
(Torres-Barcelo, 2018). A drawback that phages share
with antibiotics is emergence of phage-resistant mutants,
resulting mainly from the loss of phage receptor structures
located on the bacterial surface (lipopolysaccharide, pili,
outer membrane proteins), which are not always essential
for bacterial survival. However, administration of phage
cocktails or their combination with antibiotics could
potentially circumvent this problem (Vandenheuvel et al.,
2015; Tagliaferri et al., 2019).
So far, phage treatments have been tested in a short time
scale (<24 h) on cell cultures and in various invertebrate and
mammalian pre-clinical models (Heo et al., 2009; Alemayehu
et al., 2012; Saussereau et al., 2014; Waters et al., 2017;
Trend et al., 2018). However, the emergence of resistance
upon longer incubation times (>24 h) and the effect on host
inflammatory pathways has been studied only for S. aureus
and E. coli phages (Freyberger et al., 2018; Dufour et al.,
2019). Here, we investigated the effect of phage/antibiotic
treatments on polarized human airway epithelial cells infected
with P. aeruginosa. We found that wild type and cftr-
mutant cell lines infected with P. aeruginosa can be efficiently
treated with phages. However, prevention of emergence of
phage resistant mutants beyond 24 h required simultaneous
administration of phages and antibiotic. Using RNA expression
analyses, we further showed that phages and antibiotics
per se did not induce a pro-inflammatory response in
epithelial cells.
MATERIALS AND METHODS
Bacterial Strains, Phages and Growth
Conditions
Strains used and generated in this study are listed in Table 1.
P. aeruginosa was grown in lysogeny broth (LB) at 37◦C with
agitation (240 rpm). Phage vB_PaeP_4024 (φ24) is a N4-like
phage, closely related to the lytic phage PEV2 (KU948710.1).
Phage vB_PaeP_4054 (φ54) is a LUZ24-like phage, closely
related to the lytic phage TL (HG518155.1). These two
phages were isolated from the commercially available PYO
BACTERIOPHAGE preparation developed by the Eliava Institute
(Tbilisi, Georgia) and belong to the podoviridae family. The
phage vB_PaeS_4069 (φ69) belongs to the siphoviridae family
and was kindly provided by Christine Pourcel (University
of Paris-Sud, France). All phages yielded clear plaques on
P. aeruginosa strain PAO1 and showed different host ranges when
tested on a collection of more than 100 P. aeruginosa clinical
isolates mostly collected at the University Hospital of Lausanne
(CHUV, Supplementary Table S3).
Cell Culture
Human airway epithelial Calu-3 WILD TYPE cells (HTB-55TM)
were purchased from the American Type Culture Collection
(ATCC, Manassas, VA, United States). Calu-3 cftr- and Calu-
3 CTL, are isogenic cell lines generated by CRISPR-Cas9,
carrying respectively a CFTR knock down and a scramble
RNA construct (Bellec et al., 2015). Cells were cultivated at
37◦C in 5% CO2 in Minimum Essential Medium (MEM)
supplemented with 10% decomplemented Fetal Bovine Serum
(FBS), 1% non-essential amino acids, 1% sodium pyruvate and
1% penicillin/streptomycin and 0.25 µg/mL amphotericin B
(Fungizone). All reagents, except FBS, were purchased from Life
Technologies (Saint-Aubin, France). Well-polarized monolayers
of Calu-3 cells were obtained by seeding 175,000 cells onto 0.33-
cm2 porous (0.4 µm) Transwell polyester inserts (Transwell 3470,
Corning Life Sciences, Hazebrouck, France). The inserts were
submerged and cultured for 5 days until cells reached confluence.
Cell differentiation was induced by culturing cells at the air-liquid
interface for at least 15 days for the Calu-3 CTL and Calu-3 cftr-
epithelial cells and for at least 10 days for the Calu-3 WILD TYPE
cells. Penicillin, streptomycin and amphotericin B (Fungizone)
were removed from the cells 24 h before bacterial infection.
Secreted air-surface liquid was removed from the cells prior to
infection to allow the release of residual antibiotics from the cells.
Cell Infection and Antibacterial
Treatments
5 × 105 Calu-3 cells were polarized on Transwell filters for more
than 10 days and subsequently infected as described before (Losa
et al., 2015). Briefly, an overnight culture of P. aeruginosa PAO1
was washed and resuspended in saline buffer (NaCl 0.9%, HEPES
10 mM, CaCl2 1.2 mM) to a density of 105 CFU/ml, and 10 µl
of this suspension was added apically to the Transwell filter (i.e.,
Frontiers in Microbiology | www.frontiersin.org 2 August 2020 | Volume 11 | Article 1947
fmicb-11-01947 August 24, 2020 Time: 17:26 # 3
Luscher et al. Phage/Antibiotic Treatment of P. aeruginosa Infection
TABLE 1 | Antibiotic and phage susceptibility of phage-selected PAO1 mutants.
MICs (mg/L) Susceptibility to phage
Strain Selection CAZ CIP GEN COL AZT φ24 φ54 φ69 Genotype Phenotype
PAO1 NA 1 0.25 0.5 1 128 S S S wild type
PAO1-R1.1* φ54 (in vitro) 2 0.06 0.25 0.25 8 R R R galU,hisF2 (T20I) pyomelanin
PAO1-R1.4 φ54 (in vitro) 0.5 0.03 0.5 0.25 4 R R R algC24112bp
PT2426 φ24/69/CIP 2 0.25 0.5 1 256 R S S ND mucoid
PT2427 φ24/69/CIP 1 0.25 0.5 0.5 16 R R R galU pyomelanin
NA, not applicable; S, susceptible to phage; R, resistant to phage; CAZ, ceftazidime; CIP, ciprofloxacin; GEN, gentamicin; COL, colistin; AZT, azithromycin. *PAO1-R1.1
carries a 40 kb chromosomal deletion, including galU and the mexXY efflux pump operon.
final inoculum of 103 ± 101 CFUs, MOI of 0.002). Ten µl of saline
buffer was added on uninfected controls. Cells were incubated for
6 h at 37◦C in 5% CO2 atmosphere, before treatment was applied:
10 µl of saline buffer containing 103 ± 101 PFUs of each phage
and/or ciprofloxacin at 4 µg/ml final concentration in the apical
fluid. Ten µl of saline buffer was added on untreated controls,
and cells were incubated as above for further until 24 or 72 h post-
infection (p.i.). At each time point, trans-epithelial resistance was
measured and CFU and PFU counts were performed.
Determination of Viable Bacteria and
Infective Phage Particles
To determine the CFU and PFU counts in the wells, 200 µl
of saline buffer was added apically to the Transwell filter and
100 µl of this wash were recovered. Ten-fold serial dilutions
were performed in saline buffer and 5 µl of each dilution were
spotted on LB-agar plates (for CFU count) and on a soft-agar
PAO1 lawn (for PFU count). To quantify the individual phages
in experiments performed with cocktails, dilutions of the apical
wash were also spotted on a PAO1 mutant resistant to φ24 but
susceptible to φ69.
Whole Genome Sequencing of Bacterial
Isolates
Two isolates surviving single phage treatment were submitted to
whole genome sequencing. Bacterial DNA was extracted using
the Tissue DNA extraction kit (Qiagen) and sequenced on an
Illumina platform (single 100-bp reads with a minimum of 400×
genome coverage). After subsampling at 80× coverage, reads
were aligned against the PAO1 reference genome (AE004091.2)
using bwa mem (v0.7.15, arXiv:1303.3997v1). Variant calling was
performed using freebayes (v1.1, arXiv:1207.3907) with haploid
mode, a minimum of 10 reads coverage, 20 quality for base call
and map and 0.8 alternated fraction. Deletion of gene blocks was
searched using featureCounts (v1.6.3) with a minimum overlap
of 20 (Liao et al., 2014).
Trans-Epithelial Resistance (TER)
Measurements
Trans-epithelial resistance was measured using chopstick
electrodes as described previously (Srinivasan et al., 2015).
Briefly, at the indicated post-infection time points the Transwell
filters were transferred into a new 24-well plate containing 600 µl
of saline buffer/well. 200 µl of saline buffer were added apically
and the electrical resistance was measured in duplicate with a
volto-meter (EVOM, World Precision Instruments, Inc). Final
TERs were reported using the formula:
TER = Rmeasured () · AreaTranswell (cm2)
NanoString Gene Expression Analysis
Total RNA was extracted from epithelial cells on the Transwell
filter with the RNeasy kit according to the manufacturer’s
guidelines (Qiagen, Germany). The expression of 249
inflammatory genes was measured in uninfected and
phage/antibiotic-treated PAO1-infected epithelial cells using the
NanoString RNA detection kit (Geiss et al., 2008). Briefly, 100 ng
of RNA from Calu-3 cell lines were hybridized for 20 h at 65◦C
with inflammation pathway probes (nCounter inflammation
panel Human v2, NanoString R©). Post-hybridization washes
and bound-RNA loading on the nCounter Prep station
were processed following NanoString R© guidelines. Sample
normalization was performed on six housekeeping genes:
GUSB, HPRT1, TUBB, PGK1, CLTC, and GAPDH. A two-fold
induction was considered as significant. Purified flagellin protein
from P. aeruginosa (FLA-PA Ultrapure) was purchased from
InvivoGen (United States).
Statistical Analyses
All graphs and statistical data analyses were performed with
GraphPad Prism (version 8). One-way ANOVAs were used to
establish the significance of differences observed in the trans-
epithelial resistance measurements.
RESULTS
P. aeruginosa Lowers Trans-Epithelial
Resistance of Wild Type and cftr- Calu-3
Cell Lines
We sought in this study to compare the response of epithelial
cell lines to bacteriophages and antibiotics upon infection
with P. aeruginosa reference strain PAO1. We used three cell
lines: (i) the Calu-3 human airway cell HTB-55TM (wild type)
(Shen et al., 1994), (ii) an isogenic knock down of the CFTR
channel locus (cftr-), and (iii) the corresponding control cell
line expressing a scramble RNA (CTL) (Bellec et al., 2015).
We determined the effect of P. aeruginosa infection on cell
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layer integrity by measuring the trans-epithelial resistance (TER),
which decreases when breaches in the epithelial layer occur
(Figure 1). Apical infection of the three cell lines with 103 PAO1
CFU/well resulted in a time-dependent drop of TER, indicating
progressive disruption of the epithelial cell barrier function.
At 6 h post-infection (p.i.) the TER values for each cell line
were comparable to those of the respective uninfected control
values at 24 h, indicative of an intact epithelium. However,
at 16 h all cell lines showed significant decreases in TER,
while at 24 h, TER values were comparable to those of an
empty filter without cells (dotted line in Figure 2A). Visual
inspection of the Transwell filters under a light microscope
confirmed Disruption of the epithelial layer. To determine if
the detached Calu-3 cells 24 h p.i. were still viable, we collected
and stained these cells with trypan blue. More than 84% of
detached Calu-3 wild type cells were stained by Trypan blue
compared to 92% of uninfected Calu-3 cells but treated with
lactate dehydrogenase lysis buffer. This indicated that detached
cells were mostly dying cells resulting from infection with PAO1
(data not shown).
We next compared the PAO1 apical growth on the Calu-3
wild type, CTL and cftr- epithelial layers by CFU counting. PAO1
showed similar growth kinetics on the three cell lines starting
from 103 CFU/well and reaching 107 to 109 CFU/well at 24 h
p.i. (Figure 2B). The 2-to 3-log increase in bacterial density at
6 h p.i. did not affect TER, while progressive cell layer destruction
and cell detachment occurred thereafter for the three cell lines
(Figure 2A). We also tested twelve CF-isolates from six patients
on the Calu-3 wild type and cftr- cells. These isolates caused little
or no damage to the epithelial cell layer during 24 h incubation
(data not shown). Since this would have limited the evaluation of
phages to prevent damage to epithelial cells, we decided to pursue
the study with PAO1.
Treatment of Calu-3 Cells With
Mono-Phage or Ciprofloxacin Maintains
Epithelial Cell Integrity for 24 h p.i.
Since at 6 h p.i. the TER was not affected by P. aeruginosa
infection, although bacterial cell density had increased to ca.
106 CFU/well, we decided to use this time point to initiate
the anti-Pseudomonas treatments. We used three different
bacteriophages, vB_Pae_4024 (φ24), vB_Pae_4054 (φ54) and
vB_PaeS_4069 (φ69), as well as ciprofloxacin as a control
treatment. We added either φ54 alone at a multiplicity of
infection (MOI) of 10−4 to 101 or ciprofloxacin at 4 mg/L (16-
fold the MIC in MH broth medium) to the infected cells and
determined the TER, CFU and PFU at 24 h p.i. φ54 was chosen
for the mono-phage treatments since the plaque diameter was
larger compared to those of the other phages. Addition of phage
or ciprofloxacin, in the absence of PAO1 infection, did not affect
TER and the integrity of the cell lines was comparable to the
control after visual inspection under the microscope (Figure 3A).
Infection with P. aeruginosa PAO1 deteriorated cell integrity,
as evidenced by the low TER values at 24 h p.i. In contrast,
treatment with ciprofloxacin or φ54 even at the lowest MOI
(10−4) preserved Calu-3 cell integrity (Figure 3A). However,
ciprofloxacin or phages did not completely eradicate PAO1 cells
but led to a drop of CFUs by 4 to 6-logs, compared to the
untreated control condition (Figure 3B). Interestingly, in the
absence of any bacteria the number of infective phage particles
remained stable until the end of the incubation period. In the
FIGURE 1 | Scheme of the infection and treatment schedule. 1 × 103 bacterial cells are added at t = 0 h to a well seeded with 5 × 105 Calu-3 cells. After 6 h
incubation PAO1 has reached approximately 106 CFU/well, at which time ciprofloxacin (CIP) or three different phages alone or in combination are added apically.
Incubation is continued until 24 or 72 h, at which time point epithelial cell integrity (TER measurement), bacterial load (CFU) and phage titers (PFU) were determined.
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FIGURE 2 | Infection kinetics with P. aeruginosa PAO1 on Calu-3 cell lines.
(A) The wild type, CTL and cftr- cell lines were infected at t = 0 h with PAO1.
The CTL and cftr- cell lines showed a lower TER at t = 0 h but similar TER
values as the wild type Calu-3 cells after 16 and 24 h. (B) PAO1 showed
similar growth kinetics on the three Calu-3 cell lines. Values represent mean
and SEM (panel A), and median and range (panel B) of three independently
performed experiments. Differences in TER between the time points were
assessed using a one-way ANOVA; **p < 0.01, ***p < 0.005, ****p < 0.001.
presence of PAO1, φ54 replicated efficiently to reach similar titers
at 24 h p.i. (109 PFU/well) independently of the phage inoculum
(Figure 3C). No phage particles were detected at the basolateral
side of an uninfected Transwell filter (data not shown), suggesting
that the epithelium is impermeable to φ54.
PAO1 Escapes Mono-Phage Therapy or
Ciprofloxacin Treatment 24 h p.i.
To follow the efficacy of mono-phage therapy beyond 24 h
p.i., we further incubated the PAO1-infected Calu-3 cell lines
treated with ciprofloxacin or individual phages up to 72 h p.i.
At this time point, the TER values had dropped to 50  x cm2
for all treatment conditions, indicating disruption of epithelial
cell integrity (Figure 4A). Upon treatment with φ24 and φ54,
PAO1 CFUs dropped below detection at 24 h p.i., however
FIGURE 3 | Measurement of trans-epithelial resistance (TER), CFU and PFU
at 24 h of Calu-3 cells infected with P. aeruginosa PAO1 and treated with φ54.
(A) Phages alone do not affect TER and remain infective for 24 h. Cell integrity
is maintained by ciprofloxacin (CIP) treatment (4 mg/ml) or addition of phage
at an initial inoculum of 102 to 106 PFU/well. (B) Treatment with CIP or phage
reduces PAO1 counts after 24 h. (C) In the absence of PAO1, phage titers
remain constant during 24 h. In the presence of PAO1, phage replicate to the
same titer independent of the initial inoculum. Values represent median and
range of three independently performed experiments. Differences in TER
between the conditions were assessed using a one-way ANOVA; *p < 0.05,
**p < 0.01, ***p < 0.005.
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regrowth occurred resulting in bacterial densities close to those
of the untreated control condition at 72 p.i. (Figure 4B). Phage
replication occurred mainly during the initial 24 h, reaching
similar titers for the three phages at the end of the experiment
(Figure 4C). In the absence of bacteria, phage titers remained
stable and phages remained infective after 72 h on the epithelial
cells (Figure 4C). We hypothesized that bacterial regrowth
occurred due to phage-resistant PAO1 mutants. Two randomly
selected colonies surviving φ54 treatment were submitted to
WGS. One mutant (PAO1-R1.1) produced the brown pigment
pyomelanin and carried a 40-kb deletion encompassing the
hmgA gene (homogentisate-1,2-dioxygenase) and the galU gene
involved in LPS synthesis (Dean and Goldberg, 2002). An
additional mutation occurred in the hisF2 gene (Thr to Ile
substitution at codon 20), embedded in the O5 serotype LPS
biosynthesis operon of PAO1. The second mutant (PAO1-
R1.4) carried a 2-bp deletion in the algC gene, which is
required for LPS, alginate and Psl polysaccharide synthesis
(Table 1). Both algC and galU mutants were also resistant
to phages φ24 and φ69, suggesting that the LPS constitutes
the receptor for the three phages (Coyne et al., 1994; Dean
and Goldberg, 2002). Interestingly, both phage-resistant mutants
showed increased susceptibility to ciprofloxacin, azithromycin
and colistin (Table 1).
Phage Cocktail Combined With
Antibiotic Prevents PAO1 Regrowth
We next evaluated whether phage cocktails could prevent the
PAO1 regrowth observed at 72 h. We therefore tested a two-
phage cocktail φ24/φ69 prepared at a 1:1 ratio, either alone or
in combination with ciprofloxacin. While ciprofloxacin alone
did not prevent the drop in TER at 72 h, the phage cocktail
alone protected partially all three cell lines. Markedly, when both
treatments were combined, TER values were comparable to those
of the uninfected control, suggesting complete protection of the
epithelial cell layer (Figure 5A). P. aeruginosa CFU counts on the
apical side were undetectable (<102 CFU/well) on the wild type
and CTL cell lines 72 h p.i. (Figure 5B). A few surviving PAO1
bacteria were recovered from the phage cocktail/CIP treated
cftr- cells. One surviving colony from the combination treatment
displayed a mucoid phenotype and was resistant to phage 24,
but remained susceptible to φ69, φ54 as well as to CIP (mutant
PT2426). Another surviving colony produced again the brown
pigment pyomelanin (mutant PT2427) and was resistant to the
three phages but not to CIP (Table 1). The phages reached similar
titers on the three cell lines, which were lower by 1-2 logs in the
presence of CIP (Figure 5C). With one exception, the proportion
of φ24 and φ69 in the cocktail remained at the initial 1:1 ratio 72 h
p.i., both in the absence and presence of host bacteria, suggesting
that the two phages were not in competition with each other or
for the bacterial host (Figure 5D).
Phage-Treatment Survivors Are Less
Cytotoxic
To further characterize the two clones that survived the combined
phage/CIP treatment of the cftr- cells (Figure 5B), we infected the
FIGURE 4 | Measurement of trans-epithelial resistance (TER), CFU and PFU
at 24 and 72 h p.i. of Calu-3 cells infected by P. aeruginosa PAO1 and treated
by ciprofloxacin (CIP) or phages. (A) Single phage or CIP rescued
PAO1-infected wild type Calu-3 cells at 24 h but not at 72 h p.i. (B) PAO1
viability is reduced at 24 h by phage or CIP but returns to almost untreated
control levels after 72 h p.i. (C) phage replication increases during 72 h in
wells containing PAO1 bacteria. Values represent mean and SEM (panel A),
and median and range (panels B,C) of three independently performed
experiments. Differences in TER between the conditions were assessed using
a one-way ANOVA; **p < 0.01, ***p < 0.005.
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FIGURE 5 | Measurement of trans-epithelial resistance (TER), CFU and PFU at 72 h p.i. (A) Only combined phage and ciprofloxacin (CIP) treatment protected
epithelial cells from PAO1 infection (violet bars). (B) No viable bacteria (detection limit of 102 CFU/well) were recovered from the apical side of the wild type and CTL
cells, while surviving bacteria occurred in 2/3 experiments on the cftr-cells. (C) Phages remained at the level of the inoculum in the absence of bacteria (gray bars)
but replicated in the presence of PAO1 treated with phages alone (blue bars). CIP reduced phage replication due to killing of PAO1 host cells. (D) Phages were
added at t = 0 h at a 50:50 ratio. With the exception of the wild type cell line (blue bar), this ratio was maintained until 72 h p.i. Values represent mean and SEM
(panels A,D), and median and range (panels B,C) of three independently performed experiments. Differences in TER between the conditions were assessed using a
one-way ANOVA; *p < 0.05, **p < 0.01, ***p < 0.005.
CTL and cftr- cells with PT2426 and PT2427. Surprisingly, in the
absence of treatment the pyomelanin producing mutant PT2427
did not affect epithelial cell integrity of the CTL cell line 24 h p.i.,
but decreased eventually TER at 72 h p.i. (Figures 6A,B). The
mucoid strain PT2426 showed comparable cytotoxicity as PAO1
on both the CTL and cftr- cell lines. However, the combined
phage cocktail/CIP treatment prevented epithelial cell disruption
by both clones of CTL and cftr- cells, suggesting that the surviving
colonies were still susceptible to the cocktail/CIP combination.
Indeed, at 72 h p.i the phage cocktail/CIP treatment strongly
inhibited growth of PT2426 and PT2427 compared to the
untreated control condition (Figures 6C,D). The results indicate
that phage/antibiotic treatment does not select clones resistant to
all the constituents of the cocktail and that phage-resistant clones
might display attenuated virulence.
Phage Cocktail and Ciprofloxacin Are
Not Pro-inflammatory per se
To assess whether phages alone or in combination with
ciprofloxacin would induce a pro-inflammatory response in
Calu-3 cells, we extracted total RNA from cells exposed for
to either ciprofloxacin alone (4 mg/L), to the phage cocktail
φ24/φ69 or to the combination of both. We measured the
induction of pro-inflammatory genes using nano-string
multiplex gene expression analysis with the nCounter R©
Inflammation Panel (Human v2, nanoString Technologies,
United States). Since untreated PAO1 infection destroyed the
epithelial cell layer within 24 h, we could not extract RNA
under this condition. We therefore used purified Pseudomonas
flagellin, known to induce a TLR5-mediated inflammatory
response, as a positive control (Zhang et al., 2005; Raoust et al.,
2009). Indeed, the addition of 10 µl flagellin (1 µg/ml) at the
apical side, induced 64 out of the 249 genes detectable by the
Inflammation Panel (>two-fold induction) (Figures 7A,C and
Supplementary Table S1). The flagellin deficient fliC mutant
of PAO1 showed a strongly decreased response (36 genes
down-regulated) on Calu-3 wild type cells (data not shown). The
combination of phage and ciprofloxacin induced only ten genes
in the wild type and the CTL cells, while no induction occurred
in the cftr- cells compared to unexposed cells (Figure 7A). We
therefore studied the response of CTL and cftr- cells infected
with PAO1 and treated with phage and ciprofloxacin compared
with the uninfected control. Whatever the cell line (CTL or cftr-),
PAO1 infection induced a strong induction of pro-inflammatory
genes (Figures 7A,D; Supplementary Table S2). In the CTL
cell line 39 (at 24 h) and 48 (at 72 h) genes were up-regulated
while 61 (at 24 h) and 62 (at 72 h) genes were up-regulated in
the cftr- cells (Figures 7B,D). These data suggest that phage
particles alone or in combination with ciprofloxacin do not
induce a pro-inflammatory response, whereas flagellin and the
bacterial cell lysates trigger a strong pro-inflammatory response.
In fact, flagellin induced 26 out of the 27 genes up-regulated
in the phage-treated PAO1 cells, suggesting that flagellin is
the major trigger of the immune response to P. aeruginosa in
epithelial cells.
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FIGURE 6 | Cytotoxicity of bacteria surviving phage treatment. The cytotoxicity of PAO1-derivatives PT2426 (mucoid) and PT2527 (pyomelanin producer) were
tested in absence and presence of phage cocktail/CIP treatment at 24 and 72 h p.i. on CTL (A) and cftr- cells (B). The bacterial load at the apical side of CTL (C) and
cftr- cells (D) was determined by plate counting on LB-agar plates at 24 h and 72 h p.i. Values represent mean and SEM (panel A,B), and median and range (panels
C,D) of three independently performed experiments. Differences in TER between the conditions were assessed using a two-tailed t-test; ∗p < 0.05, ∗∗p < 0.01.
DISCUSSION
With the increase in emergence and spread of MDR bacterial
pathogens, new treatment options are urgently needed. One
alternative approach is the use of bacteriophages, since their
mode of action is usually not compromised by classical antibiotic
resistance mechanisms. CF-patients, who are often colonized
or infected by MDR or extensive drug resistant P. aeruginosa
isolates due to repeated antibiotic courses, are a prioritized
patient population for future phage trials (Morello et al.,
2011; Trend et al., 2017; Rossitto et al., 2018). Here we
investigated the efficacy of phages alone or in combination
with an antibiotic to treat wild type as well as cftr- epithelial
cell lines infected by P. aeruginosa. To our knowledge, this
is the first report on phage treatment of a cftr- epithelial
cell line. Our results show that (i) either single phage or
ciprofloxacin administration maintained epithelial cell integrity
upon P. aeruginosa infection for 24 h, (ii) only combined phage
cocktail/ciprofloxacin treatment protected wild type and cftr-
epithelial cells from P. aeruginosa infection during 72 h, (iii)
specific mutants surviving phage treatments were less cytotoxic
or more susceptible to certain antibiotics, and (iv) phage cocktails
alone or in combination with ciprofloxacin per se did not induce
a pro-inflammatory response in epithelial cells.
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FIGURE 7 | Effect of phage cocktail, ciprofloxacin (CIP) and PAO1 infection on pro-inflammatory gene expression in wild type, CTL and cftr-cell lines (A) Cells were
exposed to flagellin (positive control), as well as phage cocktail/CIP combinations for 18 h. At that point total RNA was extracted from the cells on the filter, and
submitted to nanoString analysis. Flagellin served as the positive control and showed induction of 64/249 genes of the nCounter Inflammation Panel. Phage cocktail
in combination with CIP showed induction of only a limited number of genes by the three cell lines (B) Infection of cells and subsequent treatment with phage
cocktail/CIP showed induction of 39–61 genes among the CTL and cftr- cell lines, (C) Venn Diagram showing upregulated genes 24 h post-treatment in the absence
of PAO1. The positive control flagellin showed specific induction of 48/249 genes. None of these 64 genes was up-regulated in the three cell lines by the presence of
phage cocktail/CIP. (D) Venn Diagram showing upregulated genes after 24 and 72 h treatments of PAO1 infected CTL and cftr-cell lines. cftr-cells showed a broader
pro-inflammatory response (induction of 61 (24 h) and 62 (72 h) genes), compared to the CTL cell line (induction of 39 (24 h) and 48 (72 h) genes) in the presence of
PAO1 treated with phage cocktail and CIP.
In agreement with other in vitro studies, we observed
a rapid decrease in bacterial loads upon phage treatment
at 24 h p.i. (Knezevic et al., 2013; Forti et al., 2018).
In contrast to previous studies, the Transwell filter assay
allowed us to investigate phage/bacteria/host interactions for
up to 72 h. While phage or ciprofloxacin alone could not
prevent bacterial regrowth after 24 h, a combined two-phage
cocktail/ciprofloxacin treatment decreased P. aeruginosa counts
by 6-logs at 72 h. Synergistic effects of antibiotic/phage
combinations have been reported against P. aeruginosa during
short (24 h) and long-term (7 days) exposures, including
quinolones, beta-lactams and aminoglycosides (Knezevic et al.,
2013; Torres-Barcelo et al., 2016). However, synergy seems to be
phage-dependent (Uchiyama et al., 2018), and influenced by the
order of phage/antibiotic administration (Chaudhry et al., 2017).
Phage/antibiotic synergism is not restricted to P. aeruginosa but
has been reported in other bacterial species (Zhang and Buckling,
2012; Torres-Barcelo and Hochberg, 2016). The underlying
mechanism for this synergy is not completely understood,
but could be due to antibiotic-induced cell elongation thereby
increasing the number of cell associated receptors per cell,
or to increased burst size mediated by induction of the SOS
response (Knezevic et al., 2013; Kim et al., 2018). Phage
and ciprofloxacin also synergized in a rat endocarditis model,
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where P. aeruginosa was eradicated from infected heart valves
only when ciprofloxacin was co-administered with phages
(Oechslin et al., 2017). One advantage of phage/antibiotic
synergism is the reduction of antibiotic dosage close or below
the MIC values. However, in our Calu-3 model, the high
concentration of ciprofloxacin (4 mg/L) required to obtain at
least a 4-log reduction in P. aeruginosa CFU was probably due
to the uptake of ciprofloxacin by the epithelial cells. Indeed,
ciprofloxacin both diffuses passively and is taken up actively by
Calu-3 cells (Cavet et al., 1997; Ong et al., 2013), lowering the
effective ciprofloxacin concentration on the apical side. We found
that in the absence of bacteria, phages maintained their initial
titers for 72 h at the apical side of the cells. Whether phages
adsorb, enter and transcytose epithelial cells was not investigated
here. We recovered viable phages from the basolateral side of
the epithelium only when bacteria were detected concomitantly
(data not shown), suggesting that phages may cross the epithelial
barrier once P. aeruginosa has caused localized breaches by
paracellular migration (Losa et al., 2014), but unlikely from
transcytosis, as reported in one study (Nguyen et al., 2017).
However, the study by Nguyen et al. used a different cell line and
higher phage titers under slightly acidic conditions, which could
explain this discrepancy.
Whether in vitro or ex vivo, we observed mutants
surviving phage treatment. A frequently identified mutant
population produced the brown pigment pyomelanin, secreted
by P. aeruginosa isolates deficient in the hmgA gene,
encoding homogentisate-1,2-dioxygenase. On the P. aeruginosa
chromosome this gene localizes close to the galU gene, required
for LPS synthesis, and to the mexXY efflux pump operon
(Ramos-Aires et al., 1999; Hocquet et al., 2016). These three
loci are frequently lost together as part of large chromosomal
deletions (20–250 kb), occurring mainly in isolates from
CF-patients (Hocquet et al., 2016). The deletion of a 40-kb
DNA fragment encompassing mexXY explains the hyper-
susceptibility of PAO1-R1.1 to ciprofloxacin and azithromycin.
Another in vitro selected phage-resistant mutant harbored a
frame shift in the algC gene, also required for LPS and Psl
polysaccharide synthesis (Hocquet et al., 2016; Shen et al.,
2018). Interestingly, a mutant surviving the phage cocktail
treatment was resistant to one of the two phages but not to
the other (Table 1), suggesting that careful selection of phage
combinations, preferentially with two completely different
targets, should reduce the risk of resistance selection. LPS
mutants are less virulent in animal models and do not solicit
a strong immune reaction (Goldberg et al., 1995). Indeed, the
galU mutant was less cytotoxic than the wild-type on the CTL
cell lines. Hence, phage resistance can have unexpected collateral
effects, which might be detrimental to the host bacteria and
impair its virulence (LPS mutants) or its intrinsic antibiotic
resistance (mexXY deletion). An interesting exploitation of
such collateral effects was the recently reported identification
of a phage targeting the outer membrane protein OprM of the
MexAB-OprM multidrug efflux pump of P. aeruginosa (Chan
et al., 2016). Mutants resistant to this phage through loss or
inactivation of the OprM protein were hyper-susceptible to
antibiotics and would therefore be more responsive to antibiotic
treatments than their phage susceptible wild-type parents
(Chan et al., 2016).
An important issue for future phage treatments is the
survival and innocuity of phage particles. Our data showed
that even after remaining 72 h in the air-liquid interface
without active replication, phage particles were not degraded
and remained infective. We further observed that neither phage
nor ciprofloxacin alone or in combination solicited a pro-
inflammatory response in Calu-3 wild type or cftr- cells, a
result in agreement with in vivo data (Roach et al., 2017).
Whether phages would increase or suppress the inflammatory
response due to phage-induced lysis of P. aeruginosa could not
be clearly established. However, we found that the majority of
pro-inflammatory genes up-regulated in Calu-3 cells by flagellin
were also induced by phage or antibiotic-treated P. aeruginosa,
suggesting that flagellin recognition by TLR-5 is the major
signal stimulating a host immune response (Zhang et al., 2005;
Parker and Prince, 2013). Our ex vivo model did not include
host immune cells like macrophages and neutrophils, which
assist antibiotics or phages to clear bacterial infections in the
host (Oechslin et al., 2017; Roach et al., 2017). Furthermore,
binding of phage to host proteins as well as cellular and antibody
responses and accessibility of the infection site likely affect phage
survival and treatment efficacy. However, our model would be
representative of patients with a compromised immune system
(chronic granulomatous disease) or transplant-patients receiving
life-long immune-suppressive therapies.
In conclusion, our data showed the requirement of phage
cocktail/antibiotic combinations to decrease the bacterial load
in order to avoid the emergence of resistance. Furthermore,
rational design or selection of phages recognizing essential
bacterial targets should be a promising avenue to optimize future
phage therapies.
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